Google DeepMind CEO Demis Hassabis announced at Google I/O that the company aims to revolutionize drug discovery with the ambitious goal of 'solving all disease' using AI. The announcement highlights Google's increasing focus on applying AI to healthcare and scientific research. This represents a significant commitment to using AI for major healthcare challenges, though the statement's grand scope raises questions about practical implementation.
Background
Google DeepMind has been at the forefront of applying AI to complex scientific problems, most notably with its AlphaFold protein structure prediction system. The company's expansion into drug discovery represents a natural progression of its AI capabilities in the life sciences sector.
- Source
- The Verge
- Published
- May 21, 2026 at 05:06 AM
- Score
- 7.0 / 10